EUVIMEDEUVIMED entdecken
Systematische Übersicht

Topical use of Tacrolimus in ophthalmology: A systematic review

Georgios Katonis

Aristotle University of Thessaloniki · 01.01.2024

DOI: 10.26262/heal.auth.ir.359678 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Aristotle University of Thessaloniki, erschienen am 01.01.2024. Verfasst von Georgios Katonis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Tacrolimus is an immunosuppressant drug whose administration is gradually gaining ground in the medical field of Ophthalmology, especially through topical application. It is used in several ocular and adnexal pathologies such as vernal keratoconjunctivitis and rejection prophylaxis after penetrating keratoplasty, among others. This systematic review aims to address both the efficacy and safety of topical Tacrolimus in these conditions.

Methods

A comprehensive literature search was conducted through the databases of PubMed and Cochrane Library for relevant studies published up to 16 March 2024. Studies were selected in line with specific inclusion and exclusion criteria. Data regarding the trial design, patient demographics, intervention details, and outcomes were extracted and analyzed. The extracted data were assessed for risk of bias using the Cochrane risk of bias tool (RoB 2.0).

Results

A total of 10 studies met the inclusion criteria, were retrieved, and were categorized as non-high biased after the risk of bias assessment. These studies were included in the systematic review, where a qualitative analysis took place. The efficacy and safety of Tacrolimus were evaluated in several ocular pathologies, including allergic keratoconjunctivitis, dry eye disease, ocular graft-versus-host disease, and corneal transplantation. Our analysis revealed that the topical use of Tacrolimus showed promising results as it improved clinical signs and symptoms in most patients. However, some adverse effects were noted, but they were mostly minor. Nonetheless, the methodologies used were slightly heterogeneous, and some studies had a limited patient size.

Conclusion

Tacrolimus has a promising effect on many ocular surface diseases through its topical administration. Despite the presence of some randomized controlled trials, further research and larger studies are needed to establish a consistent and evidence-based conclusion about the drug’s effectiveness and safety, alone or compared to other immunosuppressant medicat

Schlagwörter

tacrolimustopical immunosuppressantsocular surface diseasevernal keratoconjunctivitisdry eyeocular graft-versus-host diseasecorneal transplantationadverse effectsdrug efficacy

Zitieren

APA

Katonis, G. (2024). Topical use of Tacrolimus in ophthalmology: A systematic review. Aristotle University of Thessaloniki. https://doi.org/10.26262/heal.auth.ir.359678

Vancouver

Katonis G. Topical use of Tacrolimus in ophthalmology: A systematic review. Aristotle University of Thessaloniki. 2024. doi:10.26262/heal.auth.ir.359678

BibTeX
@article{Katonis2024,
  author = {Katonis, Georgios},
  title = {Topical use of Tacrolimus in ophthalmology: A systematic review},
  journal = {Aristotle University of Thessaloniki},
  year = {2024},
  doi = {10.26262/heal.auth.ir.359678}
}
Kostenlos starten →